Have “Candid Conversations” on Urothelial Cancer with Andrea Necchi, Matt Galsky, Shilpa Gupta & Michiel van der Heijden for strategies to personalize care plans with innovative #BladderCancer tx. At #ASCO24 or online 5/31 at 6:30 PM CDT. Produced with PeerView: bit.ly/2024BladderT

Rayne Rouce, associate professor at BCMHouston, was at @nih to give an NCI Center for Cancer Research #grandrounds talk on new frontiers of cancer #celltherapy & #disparities in access to these life-saving treatments. She also spoke with #NIHHemeOncFellows during our weekly Friday #didactics .

Dr. Marcia Cruz-Correa addresses the importance of making clinical trials accessible to more patients including minority and medically under-served groups including rural populations. #CancerDisparitiesReport Marcia Cruz-Correa, MD, PhD

The AACR Cancer Disparities Progress Report 2024 is now available. The report outlines the myriad factors that drive and perpetuate cancer disparities and proposes a collaborative approach to achieve #healthequity . Learn more:
bit.ly/4be2frU
#CancerDisparitiesReport

Today, CRCHD Director Dr. Sanya A. Springfield spoke alongside CURE Distinguished Scholars & Cancer Equity Leaders, Dr. Rob Winn & Marcia Cruz-Correa, MD, PhD, as well as @FDAtobacco, Margaret Foti, PhD, MD (hc), & cancer survivors at the @AACR Cancer Disparities Progress Report Congressional Briefing.

This #BladderCancerAwarenessMonth , we're honored to introduce #WorldGU24 faculty member Dr. Jonathan Rosenberg MD, a leading expert in bladder cancer research & treatment. Don't miss the opportunity to network with 50+ thought leaders at the upcoming CE event: hubs.la/Q02x0FP70

🎙️ Join the conversation on SiriusXM Ch.110 May 22nd 6:00-6:30 PM EST for Bladder Cancer Awareness Month special! Hosted by the amazing Stacy Loeb, MD, I’ll be there to dive deep into all things bladder cancer. Tune in , ask your ❓ #CancerAwareness Bladder Cancer Advocacy Network Amer. Urol. Assn.

🔍 Know the causes of #BladderCancer & how to reduce your risk:
🚭 Quit smoking
☢️ Limit exposure to harmful substances
🥦 Eat healthily & stay active
👨‍⚕️ Seek medical advice for any concerning symptoms

Let's raise awareness!

#BladderCancer Month24 World Bladder Cancer Patient Coalition

A study in BMJ Oncology suggests MMR-D/MSI-H urothelial cancer may confer high sensitivity to immunotherapy. This could spare patients the morbidity of radical surgery and the toxicities of chemotherapy.

Andrea Apolo, M.D. Elias Chandran, MBBS Giovanni Maria Iannantuono

bmjoncology.bmj.com/content/3/1/e0…

Fantastic session #AUA24 Amer. Urol. Assn. on High-Risk #UppertractUrothelialCarcinima #UTUC with our very own Nicholas Simon covering important topics on the neoadjuvant & adjuvant management based on guidelines #bladdercancer OncoAlert Oncology Brothers NCI Center for Cancer Research NCI CCR GU Malignancies

Proud to join this group for #BCAN Bladder Cancer Advocacy Network Walk! Andrea Apolo, M.D. organized the NCI BladderCancerResearchTeam, the largest group present! Dr Apolo sharing a few words on behalf of our team!

A little rain won’t stop us from joining Bladder Cancer Advocacy Network with Team Andrea Apolo, M.D. for BCAN Walk to End Bladder Cancer DC! Saad Atiq Elias Chandran, MBBS

Proud of our post-bacs students during #PostBacPosterDay NIH Clinical Center
@NIH NCI Center for Cancer Research NCI CCR GU Malignancies EDI 365. Here they present their hard work in our lab
Hooray 🎉 for Sally Weng, Nisha Kalmadi, and Ian Stukes!

Spreading awareness for Bladder Cancer! Stay tuned throughout the month for important tips and information! Bladder Cancer Advocacy Network Andrea Apolo, M.D. NCI CCR GU Malignancies

Excited to share our meta-analysis of dMMR and MSI-H in UC! These occur more in UTUC than bladder cancer. And similar to rectal cancer, occur more in localized stage, and may predict ICB sensitivity and chemoresistance. bmjoncology.bmj.com/content/3/1/e0… Andrea Apolo, M.D. Giovanni Maria Iannantuono

Join our team for the annual BCAN Bladder Cancer Advocacy Network Bladder Cancer Walk next Saturday May 4th 2024

support.bcan.org/goto/BladderCa…
#EndCancer #WeWalkTogether #NoOneWalksAlone #BladderCancer

It’s Monday #BladderCancer & #RareGUTumors Clinic ⁦National Cancer Institute⁩ ⁦NCI Center for Cancer Research⁩ ⁦NIH Clinical Center⁩. Happy Monday from the team! ⁦Nicholas Simon⁩ ⁦Elias Chandran, MBBS⁩ ⁦Dr. Andre R. Kydd⁩ ⁦Saad Atiq⁩ #EndCancer #CancerResearchSavesLives

A well-deserved honor for a great colleague!!

So much fun watching the partial #SolarEclipse NIH NCI Center for Cancer Research NIHClinicalCntr with friends and colleagues NCI CCR GU Malignancies #BladderCancer clinic and Apolo lab NCI CCR Med Onc Service

“FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive solid tumors”

Big news for #BladderCancer and all advanced cancers FDA Oncology Matt Galsky Andrea Apolo, M.D. Dr. Bishoy M. Faltas Perlmutter Cancer Center at NYU Langone Health